Familial Cold Autoinflammatory Syndrome Treatments
Find Familial Cold Autoinflammatory Syndrome Treatments
Brand Name
Arcalyst
Generic Name
Rilonacept
View Brand Information FDA approval date: February 27, 2008
Form: Injection
What is Arcalyst (Rilonacept)?
ARCALYST is an interleukin-1 blocker indicated for: Treatment of Cryopyrin-Associated Periodic Syndromes , including Familial Cold Autoinflammatory Syndrome , and Muckle-Wells Syndrome in adults and children 12 years and older.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
A RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)
Summary: The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after 24 weeks of therapy.